Senior Early Development Asset Lead

Ipsen Pharma SAS; United Kingdom; Hybrid; GBP 120.000 - 180.000; Vollzeit

Zusammenfassung

Ipsen Biopharm Ltd appoints an Early Development Asset Lead to drive integrated strategy across preclinical to first-in-human stages. The role leads the EDT, coordinating clinical, regulatory, CMC, translational, and biomarker activities to ensure rigorous, evidence-based program progression with portfolio alignment.

Strong scientific leadership, external evaluation experience, and a track record in oncology drug development are essential.

Qualifikationen

• PhD, MD, PharmD, or relevant advanced degree with a minimum 10–15 years of multidisciplinary drug development experience.

Aufgaben

• Provides program leadership and integrated strategy across preclinical to first-in-human trials.
• Leads cross-functional planning and resource allocation to balance scientific risk, timelines and cost.

Kenntnisse

Leadership

Cross-functional collaboration

Strategic thinking

Communication

Ausbildung

PhD/MD/PharmD or equivalent

Jobbeschreibung

Ipsen Biopharm Ltd appoints an Early Development Asset Lead to drive integrated strategy across preclinical to first-in-human stages. The role leads the EDT, coordinating clinical, regulatory, CMC, translational, and biomarker activities to ensure rigorous, evidence-based program progression with portfolio alignment.

Strong scientific leadership, external evaluation experience, and a track record in oncology drug development are essential.